(Q39771568)

English

High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

neoplastic invasiveness

1 reference

based on heuristic

inferred from title

author name string

Po-Len Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Jong-Rung Tsai

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Jhi-Jhu Hwang

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Shah-Hwa Chou

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Yu-Jen Cheng

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Feng-Yen Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Yuh-Lien Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Chun-Ying Hung

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Wen-Chi Chen

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Yung-Hsiang Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Inn-Wen Chong

11

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

20 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

American Journal of Respiratory Cell and Molecular Biology

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

530-538

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Staging non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Current treatments for advanced stage non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Dual roles for HMGB1: DNA binding and cytokine

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Masquerader: high mobility group box-1 and cancer

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Characterization of cDNA sequences corresponding to three distinct HMG-1 mRNA species in line CHO Chinese hamster cells and cell cycle expression of the HMG-1 gene

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Non-small cell lung cancer staging: proposed revisions to the TNM system

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Increased expression of high mobility group A proteins in lung cancer.

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Apoptosis signal-regulating kinase 1 mediates denbinobin-induced apoptosis in human lung adenocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Requirement for protein kinase C theta for cell cycle progression and formation of actin stress fibers and filopodia in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Matrix metalloproteinases and tumor metastasis

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

The other side of MMPs: protective roles in tumor progression

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Matrix metalloproteinases: roles in cancer and metastasis

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Extracellular role of HMGB1 in inflammation and sepsis.

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Differential effects between amphoterin and advanced glycation end products on colon cancer cells

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0269OC

21 January 2018

Identifiers

10.1165/RCMB.2009-0269OC

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39771568&oldid=2090162296"